Gewinn- und Verlustrechnung von Edwards Lifesciences

defenseworld.net2026-08-22 03:11:02

Allworth Financial LP Takes Position in Edwards Lifesciences Corporation $EW

Allworth Financial LP bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 16,600 shares of the medical research company's stock, valued at approximately $1,502,000. A number of other hedge funds have also

zacks.com2026-08-20 11:46:05

Should You Hold Edwards Lifesciences Stock in Your Portfolio?

EW's TAVR and TMTT growth support its outlook, but currency pressure and intense competition remain key risks.

defenseworld.net2026-08-19 03:57:47

BlackRock Inc. Acquires New Stake in Edwards Lifesciences Corporation $EW

BlackRock Inc. bought a new position in Edwards Lifesciences Corporation (NYSE: EW) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 58,789,433 shares of the medical research company's stock, valued at approximately $5,318,092,000. BlackRock Inc. owned approximately 10.21% of Edwards Lifesciences at the end

defenseworld.net2026-08-17 04:33:04

Baxter Bros Inc. Invests $3.54 Million in Edwards Lifesciences Corporation $EW

Baxter Bros Inc. purchased a new stake in shares of Edwards Lifesciences Corporation (NYSE: EW) during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 39,184 shares of the medical research company's stock, valued at approximately $3,545,000. A number of other large investors have

defenseworld.net2026-08-16 04:27:28

Bank Hapoalim BM Makes New $1.78 Million Investment in Edwards Lifesciences Corporation $EW

Bank Hapoalim BM purchased a new stake in Edwards Lifesciences Corporation (NYSE: EW) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 19,640 shares of the medical research company's stock, valued at approximately $1,777,000. A number of other large investors

zacks.com2026-08-14 12:41:13

Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?

Edwards Lifesciences pairs accelerating structural heart growth and stronger leverage with a premium valuation that leaves less room for execution setbacks.

zacks.com2026-08-13 09:55:40

Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation

Edwards' 14% three-month rally reflects broad structural-heart growth, but its premium valuation raises the bar for execution.

gurufocus.com2026-08-05 07:26:00

EW DCF Analysis: Intrinsic Value $53 vs Price $90

On August 05, 2026, we delve into the DCF analysis for Edwards Lifesciences Corp (EW), a company that has shown mixed price performance recently. The stock has

defenseworld.net2026-08-03 04:41:39

Edwards Lifesciences Corporation $EW Stock Holdings Lessened by Glenmede Trust Co. NA

Glenmede Trust Co. NA trimmed its stake in shares of Edwards Lifesciences Corporation (NYSE: EW) by 4.0% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 167,483 shares of the medical research company's stock after selling 6,923 shares

zacks.com2026-07-30 11:36:05

Is the Options Market Predicting a Spike in Edwards Lifesciences Stock?

Investors need to pay close attention to EW stock based on the movements in the options market lately.

Erläuterung zur Gewinn- und Verlustrechnung

Erläuterung zur Ertragskraft

Gewinn- und Verlustrechnung von Edwards Lifesciences Corporation

Erläuterung zur Gewinn- und Verlustrechnung

Erläuterung zur Ertragskraft